Document Detail


Evidence of how rs7575840 influences apolipoprotein B-containing lipid particles.
MedLine Citation:
PMID:  21393584     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Recent genome-wide association studies identified a variant rs7575840 in the apolipoprotein B (APOB) gene region as associated with low-density lipoprotein (LDL) cholesterol. However, the underlying functional mechanism of this variant, which resides 6.5 kb upstream of APOB, has remained unknown. Our objective was to investigate rs7575840 for association with refined apoB-containing lipid particles, for replication in a Mexican population, and for its underlying functional mechanism.
METHODS AND RESULTS: Our data show that rs7575840 is associated with serum apoB levels (P=4.85×10(-10)) and apoB-containing lipid particles, very small very-low-density lipoprotein, intermediate lipoprotein, and LDL particles (P=2×10(-5) to 9×10(-7)) in the Finnish Metabolic Syndrome in Men study sample (n=7710). Fine mapping of the APOB region using 43 single-nucleotide polymorphisms replicated the association of rs7575840 with apoB in a Mexican study sample (n=2666, P=3.33×10(-5)). Furthermore, our transcript analyses of adipose RNA samples from 175 subjects in the Finnish Metabolic Syndrome in Men study indicate that rs7575840 alters expression of APOB (P=1.13×10(-10)) and a regional noncoding RNA (BU630349) (P=7.86×10(-6)) in adipose tissue.
CONCLUSIONS: It has been difficult to convert genome-wide association study associations into mechanistic insights. Our data show that rs7575840 is associated with serum apoB levels and apoB-containing lipid particles, as well as influencing expression of APOB and a regional transcript BU630349 in adipose tissue. We thus provide evidence how a common genome-wide significant single-nucleotide polymorphism, rs7575840, may affect serum apoB, LDL cholesterol, and total cholesterol levels.
Authors:
Blake E Haas; Daphna Weissglas-Volkov; Carlos A Aguilar-Salinas; Elina Nikkola; Laurent Vergnes; Ivette Cruz-Bautista; Laura Riba; Alena Stancakova; Johanna Kuusisto; Pasi Soininen; Antti J Kangas; Mika Ala-Korpela; Teresa Tusie-Luna; Markku Laakso; Päivi Pajukanta
Related Documents :
17609584 - Development of numerous nerve fibers in the epidermis of hairless mice with atopic derm...
1543694 - Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in di...
9713814 - Morphometry of fine structural alterations of hepatocytes of japanese monkeys under fas...
21450674 - Ldl cholesterol goals and cardiovascular risk during statin treatment: the ideal study.
18046594 - Comparison of low fat and low carbohydrate diets on circulating fatty acid composition ...
205554 - Catabolism of very low density lipoprotein b apoprotein in man.
Publication Detail:
Type:  Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2011-03-10
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  31     ISSN:  1524-4636     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-04-21     Completed Date:  2011-06-24     Revised Date:  2012-05-02    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1201-7     Citation Subset:  IM    
Affiliation:
Department of Human Genetics, David Geffen School of Medicine at the University of California, Los Angeles, Gonda Center, Rm 6335B, 695 Charles E. Young Dr S, Los Angeles, CA 90095-7088, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adipose Tissue / metabolism
Aged
Apolipoproteins B / blood,  genetics*
Biological Markers / blood
Case-Control Studies
Cholesterol, LDL / blood
European Continental Ancestry Group / genetics
Finland / epidemiology
Gene Frequency
Genetic Predisposition to Disease
Genome-Wide Association Study
Humans
Hypertriglyceridemia / blood,  ethnology,  genetics*
Indians, North American / genetics
Linear Models
Lipoproteins, IDL / blood
Lipoproteins, LDL / blood
Lipoproteins, VLDL / blood
Male
Mexico / epidemiology
Middle Aged
Particle Size
Pedigree
Phenotype
Polymorphism, Single Nucleotide*
Risk Assessment
Risk Factors
Triglycerides / blood
Grant Support
ID/Acronym/Agency:
HL-095056/HL/NHLBI NIH HHS; HL-28481/HL/NHLBI NIH HHS; P01 HL028481-23/HL/NHLBI NIH HHS; R01 HL095056-01/HL/NHLBI NIH HHS; R01 HL095056-02/HL/NHLBI NIH HHS; R01 HL095056-03/HL/NHLBI NIH HHS; R01 HL095056-04/HL/NHLBI NIH HHS; T32 HG002536-01/HG/NHGRI NIH HHS; T32 HG02536/HG/NHGRI NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoproteins B; 0/Biological Markers; 0/Cholesterol, LDL; 0/Lipoproteins, IDL; 0/Lipoproteins, LDL; 0/Lipoproteins, VLDL; 0/Triglycerides

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and i...
Next Document:  Angiogenic and Vasoprotective Effects of Adrenomedullin on Prevention of Cognitive Decline After Chr...